Safety of daprodustat in patients with anemia of chronic kidney disease: A pooled analysis of phase 3 studies in Japan

INTRODUCTION: Daprodustat is an approved treatment for anemia of chronic kidney disease (CKD) in Japan. METHODS: This post hoc analysis evaluated pooled safety data for daprodustat from 3 phase 3 Japanese studies in dialysis‐dependent and nondialysis patients with anemia of CKD. RESULTS: Median drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Nangaku, Masaomi, Akizawa, Tadao, Nagakubo, Takashi, Yonekawa, Taeko, Kimura, Toshifumi, Endo, Yukihiro, Cobitz, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790622/
https://www.ncbi.nlm.nih.gov/pubmed/35312234
http://dx.doi.org/10.1111/1744-9987.13839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790622/
https://www.ncbi.nlm.nih.gov/pubmed/35312234
http://dx.doi.org/10.1111/1744-9987.13839

Ejemplares similares